Compare these too: Iambic Therapeutics, Inc. · Superluminal Medicines, Inc. · Airway Therapeutics, Inc. · Gossamer Bio, Inc. · Cloverleaf Bio, Inc.
← The full ALZHEON, INC. record · every deck on file · all funding signals
Against the 15 raises on file in Biotechnology. Median $5.60M, largest $78.80M.
How does your raise compare?
Enter an amount to place it against the filings on record.
Percentiles are drawn from the 1403 Form D filings held here that state an amount, filed between 3 and 11 September 2026 — 1371 of them in the 19 industry groups large enough to rank against (5 filings minimum).
| Rank | Company | Score | Raise size | Filed | People named | Investors in | Form D cadence | Filing history |
|---|---|---|---|---|---|---|---|---|
| 1 | Iambic Therapeutics, Inc.leads | 94 | $65.97M · 93rd pctadds 36 | 2026-09-09 · 3d agoadds 23 | 13adds 23 | 16adds 12 | not stated | not stated |
| 2 | ALZHEON, INC.this page | 92 | $78.80M · 100th pctadds 38 | 2026-09-10 · 2d agoadds 23 | 12adds 23 | 3adds 8 | not stated | not stated |
| 3 | Gossamer Bio, Inc. | 89 | $25M · 71st pctadds 28 | 2026-09-04 · 8d agoadds 23 | 11adds 23 | 38adds 15 | 6not scored | 467 since 2018not scored |
| 4 | Airway Therapeutics, Inc. | 82 | $43.50M · 79th pctadds 31 | 2026-09-09 · 3d agoadds 23 | 5adds 12 | 116adds 16 | not stated | not stated |
| 4 | Superluminal Medicines, Inc. | 82 | $65.48M · 86th pctadds 34 | 2026-09-03 · 9d agoadds 23 | 5adds 13 | 16adds 12 | 4not scored | 4 since 2023not scored |
| 6 | Cloverleaf Bio, Inc. | 72 | $14.80M · 64th pctadds 25 | 2026-09-09 · 3d agoadds 23 | 5adds 12 | 12adds 12 | not stated | not stated |
A score out of 100 comparing what each company's record shows for raise size within its industry group, filing recency, people named on the filing and investors disclosed.
- Raise size within its industry groupup to 39
- Filing recencyup to 23
- People named on the filingup to 23
- Investors disclosedup to 15
- Form D cadence and filing history depthshown, not scored
- 75 and up
- 55 to 74
- 35 to 54
- under 35
| Company | On the record | Industry group | Filed |
|---|---|---|---|
| Iambic Therapeutics, Inc. | $65.97M | Biotechnology | 2026-09-09 |
| Superluminal Medicines, Inc. | $65.48M | Biotechnology | 2026-09-03 |
| Airway Therapeutics, Inc. | $43.50M | Biotechnology | 2026-09-09 |
| Gossamer Bio, Inc. | $25M | Biotechnology | 2026-09-04 |
| Cloverleaf Bio, Inc. | $14.80M | Biotechnology | 2026-09-09 |
| Tempo Therapeutics, Inc. | $14M | Biotechnology | 2026-09-11 |
| Praeventix, Inc. | $5.60M | Biotechnology | 2026-09-10 |
| Episteme Prognostics, Inc. | $5.09M | Biotechnology | 2026-09-04 |
| Episteme Prognostics, Inc. | $5.09M | Biotechnology | 2026-09-04 |
| Polyrizon Ltd. | $4M | Biotechnology | 2026-09-10 |
| BioLineRx Ltd. | $3.75M | Biotechnology | 2026-09-09 |
| Pluri Inc. | $3.68M | Biotechnology | 2026-09-04 |
| Therapeutic Neuromodulation Systems LLC | $970K | Biotechnology | 2026-09-11 |
| Amplica Bio, Inc. | $30K | Biotechnology | 2026-09-11 |
| ALZHEON, INC. (this page) | $78.80M | Biotechnology | 2026-09-10 |
14 other records here are in this industry group.
How this list is chosen
Nearest by stated offering size, inside the industry group the filing itself declares (Biotechnology). Nothing is inferred about what a company does.
